EyePoint Pharmaceuticals
EYPT
EYPT
45 hedge funds and large institutions have $104M invested in EyePoint Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.83% less ownership
Funds ownership: 6.63% → 5.8% (-0.83%)
41% less capital invested
Capital invested by funds: $176M → $104M (-$72.3M)
Holders
45
Holding in Top 10
1
Calls
$336K
Puts
$167K
Top Buyers
| 1 | +$5.02M | |
| 2 | +$2.04M | |
| 3 | +$1.38M | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$820K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$549K |
Top Sellers
| 1 | -$702K | |
| 2 | -$513K | |
| 3 | -$278K | |
| 4 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$164K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$151K |